Comparative Study for Clinical Outcomes of Triple-Positive and Triple-Negative Breast Cancer: Long-term Results in 161 Patients Followed in a Single Center

Seungyeol Baeg; Inseok Park; Jungbin Kim; Chansub Park; Hyunjin Cho; Keunho Yang; Jiyoung Kim; Youngjoo Shin; Kyeongmee Park; Geumhee Gwak

추천

검색

자료유형: 학술저널

저자정보: Seungyeol Baeg Inseok Park Jungbin Kim Chansub Park Hyunjin Cho Keunho Yang Jiyoung Kim Youngjoo Shin Kyeongmee Park Geumhee Gwak

저널정보: 한국유방암학회 Journal of Breast Disease Journal of Breast Disease 제8권 제1호

발행연도: 2020.1

수록면: 78 - 84 (7page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Purpose: Triple negative breast cancer (TNBC) is one of the most aggressive subtypes of breast cancer. However, we have often experienced that triple positive breast cancer (TPBC) shows more aggressive clinical features than TNBC. In this retrospective study, we aimed to examine the differences in clinical courses between TNBC and TPBC. Methods: Using medical records and clinical data, we selected patients with breast cancer who met the criteria for the two groups, TNBC and TPBC, based on the expression or absence of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2). We then compared these groups with respect to clinical and pathological variables, such as patient age at diagnosis, TNM stage, number of tumors, involvement of resection margin, operation methods, histologic grade (HG), nuclear grade (NG), and lymphatic invasion (LI). We also compared the disease-free (DFS) and overall survival (OS) outcomes between the groups. Results: Seventy patients with TNBC and 91 with TPBC were identified among a total of 628 patients. In univariate analysis, TPBC was significantly more frequently associated with lower HG (p=0.001), lower NG (p=0.003), LI (p=0.001), and a Ki-67 index ≤20% (p<0.001). In multivariate analysis, a lower Ki-67 index (p=0.031) and LI (p=0.022) were identified as significant and independent factors contributing to DFS. In a survival analysis over time, the TPBC showed a worse OS than TNBC 5 years post-treatment for breast cancer. Consequently, the TPBC group had definite worse 10-year DFS (p=0.012) and showed relatively lower OS rate (p=0.058), than the TNBC group. Conclusion: Our results demonstrate considerable differences in long-term post-treatment survival of patients with TPBC and TNBC. Further studies to determine the proper management of both types of breast cancer and an accurate prognostic evaluation method are warranted.

참고문헌 (27)

참고문헌 신청

Kamdje AHN / 2014 / Signaling pathways in breast cancer : therapeutic targeting of the microenvironment / Cell Signal 26:2843~2856

The cancer genome atlas network / 2012 / Comprehensive molecular portraits of human breast tumours / Nature 490:61~70

Clark GM / 1984 / Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer / J Clin Oncol 2:1102~1109

Perou CM / 2000 / Molecular portraits of human breast tumours / Nature 406:747~752

Konecny G / 2003 / Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer / J Natl Cancer Inst 95:142~153

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!